Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05524545
Title A Study of Evorpacept (ALX148) With Enfortumab Vedotin for Subjects With Urothelial Carcinoma (ASPEN-07)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors ALX Oncology Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Moffitt Cancer Center RECRUITING Tampa Florida 33612 United States Details
University of Chicago Medicine NOT_YET_RECRUITING Chicago Illinois 60637 United States Details
Massachusett's General RECRUITING Boston Massachusetts 02114 United States Details
Memorial Sloan Kettering Cancer Center RECRUITING New York New York 10065 United States Details
University of North Carolina RECRUITING Chapel Hill North Carolina 27599 United States Details
Oregon Health & Science University RECRUITING Portland Oregon 97239 United States Details
West Clinic RECRUITING Germantown Tennessee 38138 United States Details
UT Southwestern RECRUITING Dallas Texas 75390 United States Details
Seattle Cancer Care Alliance RECRUITING Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field